Synthego Corporation

🌟 We're proud to announce that Lina Jamis, our Associate Director of Regulatory Affairs and Compliance at Synthego, will be attending the Cell & Gene Regulatory Affairs Summit! This prestigious event is a cornerstone for industry leaders to discuss and shape the future of regulatory frameworks in cell and gene therapy. Lina will be there to share insights, engage in discussions, and bring back valuable knowledge to help us drive innovation and excellence at Synthego. Her participation underscores our commitment to staying at the forefront of regulatory advancements and ensuring our solutions meet the highest standards. If you're attending the summit, be sure to connect with Lina to discuss the latest trends and explore collaborative opportunities. Follow our page for updates and insights from the event. We’re excited to be part of this vibrant community! 🚀 #RegulatoryAffairs #CellAndGeneTherapy

What a KNOCKOUT team! Celebrating these #synthegoats who just hit a milestone with us in October. 1 year - Ngoc L., Marjan Varedi, PhD, Loren Thai 2 years - Kacey Su, Roelyne Reyes, Hoan Nguyen 3 years - Jonas Ng, Eric Tablante 5 years - Anthony Ton, Justin Guasque

How is it already day 3 of #ESGCT24?! The time has flown by this week. Our team is buzzing with the energy of so many amazing conversations. Big thanks to everyone who's already stopped by to chat. Remember to check out our posters from Kevin Holden and Tal Shamia at tonight's poster session. And if you haven't stopped by our booth D09 yet, please do - we want to hear about your gene editing projects!

While there's so much innovative work being presented at #ESGCT24, don't forget to make time to visit Synthego's posters to learn more about our next-generation strategies to help you reach your therapeutic goals. Want a sneak peek? Stop by our Booth D09 to chat before the poster session and get in-depth with our CRISPR experts! Tal Shamia Artur Gittos Kevin Holden Sameer Moorji Jason Miller

Planning your #ESGCT24 itinerary? Make sure Synthego is on your list! Visit our booth to explore our newest product for clinical master cell bank creation - iPSC gRNAs - and discover how our novel nucleases and simplified licensing can accelerate your therapeutic development. Safe travels to all attendees—we look forward to connecting with you and sharing exciting insights. Let's make ESGCT a remarkable experience together! Tal Shamia Artur Gittos Kevin Holden Sameer Moorji Jason Miller

At Synthego, our commitment to helping others find cures for diseases extends beyond the lab and into the community. This year, we proudly participated in the Pinkathon 2024 Challenge, joining the fight against breast cancer. Our team came together not just to make generous donations, but to hit the pavement with purpose. After our walk, we celebrated with some delicious pink-themed cupcakes, a sweet reminder that every step—and every donation—brings us closer to a world without breast cancer. Together, we’re not just curing diseases in the lab, we’re making a real impact in our communities, one step at a time!

⭐️ Team Highlight: DNA Committee! ️️⭐️ The DNA Committee is dedicated to celebrating diversity, advocating for equity, and fostering inclusivity—making Synthego a place where everyone feels valued, heard, and empowered to bring their authentic selves to work. ❤️ 🧡 💛  💚 💙 💜 🩷 🤎 🤍 🖤 This amazing team also leads the way in organizing events that celebrate holidays, heritage months, and special days throughout the year, bringing us all together to honor and embrace our unique backgrounds. 🎉 Their goal is to create a thriving workplace and community by embedding these principles into our very core—our DNA. 🧬 Get to know the incredible team behind our DNA Committee:  Row 1 - Enessa Rezig, Ngoc Ly, Lory Tan Row 2 - Yvonne Asuncion, Andrea E., Raminder Hayre Row 3 - Michael Molnar, Ph.D., Shannon Leary, Emily Watkins Row 4 - Stephen Dudek, James Vannasing, Lisa Hazen

We're excited to be exhibiting next week at #ESGCT24! Visit our Booth D09 to learn more about our best-in-class CRISPR solutions, including: 🧬 iPSC gRNAs specifically for creating clinical iPSC master cell banks ✂️ hfCas12Max engineered for high performance in CRISPR therapeutics 📋 Regulatory expertise to guide you through this phase and the next Stop by and chat with Tal Shamia, Artur Gittos, Sameer Moorji, and Kevin Holden to learn more and catch up on the latest news and trends in CRISPR gene editing. See you there!!

Are you in Europe and need a Guide (RNA)? Have you considered exploring alternative CRISPR nucleases for your work? Does navigating the regulatory landscape to develop therapeutics seem daunting? If you said yes to any of these, Kevin Holden and Artur Gittos are hosting a seminar on November 4th in Paris that covers all of those topics and more! 🇫🇷 Registration can be found here: https://lnkd.in/gKZCMGBM We will see you there! #CRISPR

🎉 Exciting news from Synthego! 🎉 We're thrilled to announce our newest product: iPSC gRNA Our iPSC gRNA offers an efficient and cost-effective solution for CRISPR-edited clinical iPSC master cell bank creation. What you get: ✔ Streamlined Procurement ✔ Quality Assurance ✔ Consistent Delivery Check it out 👉 https://lnkd.in/gc3fXegS Or Contact Us to learn more 👉 https://lnkd.in/gJhHRejp